871798-85-5 Usage
Chemical structure
A heterocyclic compound with a cyclohepta[c]pyridine ring system fused with a tetrahydropyridine ring and a pyridine ring attached at the 1-position.
Unique structure
The compound has a distinctive arrangement of its constituent rings, which may contribute to its potential pharmacological and biological activities.
Potential applications
Due to its structural features, 1-(Pyridin-2-yl)-6,7,8,9-tetrahydro-5H-cyclohepta[c]pyridine may have applications in medicinal chemistry research.
Pharmacological and biological activities
The compound's specific properties and potential applications would require further investigation and study to determine its pharmacological and biological activities.
Subject of interest
As a result of its unique structure and potential applications, 1-(Pyridin-2-yl)-6,7,8,9-tetrahydro-5H-cyclohepta[c]pyridine is a subject of interest in the field of medicinal chemistry.
Further research needed
The compound's specific properties, potential applications, and pharmacological and biological activities would need to be explored through additional research and study to fully understand its capabilities and potential uses.
Check Digit Verification of cas no
The CAS Registry Mumber 871798-85-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,1,7,9 and 8 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 871798-85:
(8*8)+(7*7)+(6*1)+(5*7)+(4*9)+(3*8)+(2*8)+(1*5)=235
235 % 10 = 5
So 871798-85-5 is a valid CAS Registry Number.
871798-85-5Relevant academic research and scientific papers
Improved methodologies for the preparation of highly substituted pyridines
Sainz, Yolanda Fernandez,Raw, Steven A.,Taylor, Richard J. K.
, p. 10086 - 10095 (2007/10/03)
Two separate strategies have been developed for the preparation of highly substituted pyridines from 1,2,4-triazines via the inverse-electron-demand Diels-Alder reaction: a microwave-promoted, solvent-free procedure and a tethered imine-enamine (TIE) appr
